share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

辉瑞 | 4:持股变动声明-高管 BOURLA ALBERT
美股sec公告 ·  06/04 17:08
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
2024年5月31日,辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布尔拉执行了一项非衍生证券的交易。 根据提供的公告,交易的具体细节,包括股份数量,交易价格和总价值,尚未披露。 这一行动反映了布尔拉在公司中的持股变动,但在没有更多信息的情况下,无法确定该行动对其所持有的总股份数产生的影响。
2024年5月31日,辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布尔拉执行了一项非衍生证券的交易。 根据提供的公告,交易的具体细节,包括股份数量,交易价格和总价值,尚未披露。 这一行动反映了布尔拉在公司中的持股变动,但在没有更多信息的情况下,无法确定该行动对其所持有的总股份数产生的影响。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息